期刊
BIOCONJUGATE CHEMISTRY
卷 28, 期 10, 页码 2569-2574出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.bioconjchem.7b00410
关键词
-
类别
资金
- Israel Science Foundation [1589/14]
- Russian Science Foundation [14-24-00106]
- Far Unimore project
- Russian Science Foundation [17-24-00006] Funding Source: Russian Science Foundation
We demonstrate that the designed ankyrin repeat protein (DARPin)_9-29, which specifically targets human epidermal growth factor receptor 2 (HER 2), binds tightly to gold nanoparticles (GNPs). Binding of the protein strongly increases the colloidal stability of the particles. The results of experimental analysis and molecular dynamics simulations show that approximately 35 DARPin_9-29 molecules are bound to the surface of a 5 nm GNP and that the binding does not involve the receptor-binding domain of the protein. The confocal fluorescent microscopy studies show that the DARPin-coated GNP conjugate specifically interacts with the surface of human cancer cells overexpressing epidermal growth factor receptor 2 (HER2) and enters the cells by endocytosis. The high stability under physiological conditions and high affinity to the receptors overexpressed by cancer cells make conjugates of plasmonic gold nanostructures with DARPin molecules promising candidates for cancer therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据